Nanoparticles can enhance insulin delivery in several ways:
Protection from Degradation: Insulin encapsulated within nanoparticles is shielded from enzymatic degradation in the gastrointestinal tract, improving its bioavailability. Controlled Release: Nanoparticles can be engineered to release insulin in a controlled manner, mimicking the physiological release and reducing the frequency of administration. Targeted Delivery: Functionalization of nanoparticles with specific ligands allows for targeted delivery to tissues such as the liver, where insulin action is most needed.
